OTO Fertility has launched what it claims is a world-first AI fertility prediction platform and wearable to forecast treatment outcomes. The Toronto-based company says its system...
Megestrol, a hot flush drug for breast cancer patients, may also curb tumours when added to standard hormone therapy, an early trial has found. The PIONEER...
Femtech World explores the latest business developments in the world of women’s health. FemHealth Ventures closes oversubscribed US$65m Fund II FemHealth Ventures, a women’s health-focused venture...
A petition calling on the UK government to introduce menstrual leave for women with gynaecological conditions has gathered nearly 75,000 signatures. The campaign needs 100,000 signatures...
Women experience slightly worse recovery than men in the first year after stroke, with more difficulty with daily tasks such as eating, dressing and driving. The...
Caesarean births (surgical births) have overtaken vaginal deliveries in England for the first time, with 45 per cent of births now by caesarean, NHS data show....
A large real-world study has found that an AI-powered digital tool developed by Megi Health can significantly reduce blood pressure over time while maintaining high long-term...
A team of UK researchers has published a new study examining how middle-aged, middle-class British women describe the effects of regular open water swimming on their...
Ultromics, a developer of AI-driven cardiology solutions, has announced an investment from the American Heart Association’s Go Red for Women Venture Fund, a fund within American...
Wales has opened its first women’s health research centre, backed by £3m to tackle health inequalities through research and innovation. The centre, led by Women’s Health...
